WVE Overview
Upcoming Projects (WVE)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (WVE)
-
Reviewing the recent Duchenne Muscular Dystrophy Data from Wave Life Sciences on their exon 53 skipper, WVE-N531
Tickers: WVE, SRPT, RNA, NS Pharma
Executed On: Sep 26, 2024 at 11:00 AM EDT
Upcoming & Overdue Catalysts (WVE)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (WVE)
-
Phase 1b/2a top line data of Wave Life Science(WVE) WVE-120102 (PRECISION-HD2) in mutant huntingtin (mHTT) 32 mg data due 1Q 2021
Ticker: WVE
Occurred on: Mar 29, 2021 -
Wave Life Sciences(WVE) Receives Fast Track Designation from FDA for Suvodirsen
Ticker: WVE
Occurred on: Sep 16, 2019 -
WAVE Life Sciences Receives Orphan Drug Designation from FDA for its Lead Candidate Designed to Treat Huntington’s Disease
Ticker: WVE
Occurred on: Jun 21, 2016
Strategic Initiatives (WVE)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
